Cochlear Implant Speech and Non-speech Sound Recognition

NCT ID: NCT03661970

Last Updated: 2024-02-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

10 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-06-10

Study Completion Date

2023-04-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of the research is to study how synthesized speech and non-speech percepts (sounds) are recognized in subjects with cochlear implants (CI) who are not getting functional speech recognition using existing speech to CI algorithms. By identifying a partial set of phonemes (units of speech) from this CI feedback, a new language could be developed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A cochlear implant (CI) is a small, complex electronic device used by the profoundly deaf or severely hard-of-hearing. The CI has two main components: 1. The externally worn microphone, sound processor and transmitter system; 2. The implanted receiver and electrode system sending electrical currents to the inner ear; whereby the external and internal components are held together by a magnet. The CI does not restore normal hearing; however, it does provide a small representation of sounds in the environment and help him or her to understand speech. Due to the limited capacity of the CI, hearing is vastly different from normal hearing and it is difficult to really understand what they are hearing; hence, the varying outcomes of CI users. Most of the current research on cochlear implants (CI) aims to improve speech recognition for spoken English. However, patients who have a cochlear implant late in life-basically after childhood-have a very limited ability to learn speech. Late implant CI recipients do not distinguish speech sounds well, but it is not known if non-speech sounds can be differentiated, and if so, whether they can be used to create a functional language. Honeder et al studied the latest CI to determine the impact of a new audio processor on speech perception in noise. Overall, this new CI may improve hearing performance especially in difficult listening situations; however, due to inconsistencies in technical setups, speech processors, coding strategies, spatial conditions, spectral and temporal noise characteristics, speech testing paradigms, and subjects' ear they were unable to find significant improvements. Thus, demonstrating the challenge of understanding truly, what CI users hear and understand.

Usher Syndrome is the most common inherited condition where children are born with moderate to profound hearing loss, depending on the type affecting. Usher syndrome affects approximately 4 to 17 per 100,000 people, and accounts for about 50 percent of all hereditary deaf-blindness cases. Usher's syndrome affects three to six percent of all children who are deaf and who are hard-of-hearing. Of the three types, types 1 and 2 are the most common and make up about 95% of the reported cases. Since genetic factors are the most commonly known etiology for Usher's Syndrome, it is very difficult to know what exactly the effected patient might hear or understand while using a CI. A systematic review by Nishio et al showed relatively good CI outcomes; however, there have only been limited studies conducted on patients with other gene mutations. Overall, CI patients report improvements in speech and quality of life. Unfortunately, the exact mechanisms of how and what Usher Syndrome CI users' process still requires further investigation.

Despite the historical usage and various advancements in computer technology for CIs, the hearing world has yet to implement underutilized methodology and technology to further train, assess, and advance the capabilities of CIs. More importantly, simulation hearing labs providing a standardized, patient controlled environment with high-fidelity tracking and monitoring hearing simulations using a keyboard synthesizer (Cognate) attached to an external CI will allow for a more comprehensive evaluation of the CI users' hearing experience, assimilation, interpretation, and user controlled actions. Cognate is a simplified and more structured speech synthesizer. The synthesizer will generate the CI output, an acoustic output, and a visual display of the acoustic signals and CI output on the monitor and record the outputs of the synthesizer. Cognate would be an alternate 'English' encoding CI system that might be simpler to learn, and would translate written English, not spoken English. Cognate would translate text into percepts (sounds) that the subject would 'hear'. These percepts (sounds) would be equivalent in a sense to phonemes (letters). With a partial set of phonemes (English uses 45 for very computer sounding speech synthesis), a new language could be developed. The feasibility and data from this study will be used for future studies to evolve the Cognate encoding CI system, especially for Usher Syndrome patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Deafness Sound Perception Quality of Sound

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal subjects hearing group

After education on the use of the Cognate Speech Synthesizer the participant will be asked to demonstrate specific tasks on the Cognate Speech Synthesizer testing their search patterns of interests, use-ability, and acoustic vamp values on the Cognate Speech Synthesizer.

Cognate Speech Synthesizer sound percepts

Intervention Type OTHER

The cognate speech synthesizer will generate an acoustic output, as well as a visual display of the acoustic signals. The outputs on the monitor and the synthesizer will be recorded.

Cochlear implant subjects with good speech recognition

After education on the use of the Cognate Speech Synthesizer the participant will be asked to demonstrate specific tasks on the Cognate Speech Synthesizer testing their search patterns of interests, use-ability, and acoustic vamp values on the Cognate Speech Synthesizer.

Cognate Speech Synthesizer sound percepts

Intervention Type OTHER

The cognate speech synthesizer will generate an acoustic output, as well as a visual display of the acoustic signals. The outputs on the monitor and the synthesizer will be recorded.

Cochlear implant subjects without good speech recognition

After education on the use of the Cognate Speech Synthesizer the participant will be asked to demonstrate specific tasks on the Cognate Speech Synthesizer testing their search patterns of interests, use-ability, and acoustic vamp values on the Cognate Speech Synthesizer.

Cognate Speech Synthesizer sound percepts

Intervention Type OTHER

The cognate speech synthesizer will generate an acoustic output, as well as a visual display of the acoustic signals. The outputs on the monitor and the synthesizer will be recorded.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognate Speech Synthesizer sound percepts

The cognate speech synthesizer will generate an acoustic output, as well as a visual display of the acoustic signals. The outputs on the monitor and the synthesizer will be recorded.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults who are at least 18 years of age
* Must have normal visual acuity as evidenced by the ability to read and write notes to and from study staff when necessary
* Must be fluent reading and writing English
* No confounding or concomitant medical issues except for deafness
* Must be able to understand and perform assigned tasks
* Must be computer literate
* Normal hearing OR adult with compatible cochlear implant (Cochlear Nucleus 24 series cochlear implants)

Exclusion Criteria

* Incompatible Cochlear Implant device
* Less than 18 years of age
* Not able to speak, read, or write English
* Adult with less than six month's experience with their CI
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cadwell Industries, Inc.

INDUSTRY

Sponsor Role collaborator

Pacific Northwest University of Health Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John Cadwell, MD

Role: PRINCIPAL_INVESTIGATOR

Affiliate Faculty

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cadwell Industries Inc

Kennewick, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018-006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.